Skip to main content

'Future-proofing' blood processing for measurement of circulating microRNAs in samples from biobanks and prospective clinical trials.

Murray MJ, Watson HL, Ward DM, Bailey S, Ferraresso M, Nicholson JC, Gnanapragasam VJ, Thomas B, Scarpini CG, Coleman N

Publication: Cancer Epidemiol Biomarkers Prev (2017)PMID: 29254935View on PubMed

Purpose

The purpose of this paper was to determine the effects of blood collection tube type, extraction method, and centrifugation delays on levels of miRNA in plasma and serum. The effects of centrifugation delays and tube type on hemolysis were also investigated using different assessment methods.

Conclusion

miRNA levels were highest in serum followed by EDTA plasma and Streck DNA plasma. The miRNA levels were much lower in specimens collected in Streck RNA tubes and were not improved by changes in the extraction method. Although hemolysis increased with pre-centrifugation storage of blood in EDTA or Streck DNA tubes and was detected using real-time PCR in almost all specimens regardless of centrifugation delay, hemolysis as determined by visual inspection and by spectrophotometry was only detected in specimens stored for at least 7 days in Streck DNA tubes or 1 h in EDTA tubes. Use of a second centrifugation step or a high speed centrifugation step to obtain EDTA plasma reduced the recovery of miRNA. Use of the Norgen plasma/serum RNA purification kit reduced the variability in miRNA quantification compared to when extraction was performed with the Qiagen miRNeasy serum/plasma kit, but the CT values were still higher for plasma than for serum and were not improved by the addition of a proteinase K step.

Studies (5)

Purpose

This study compared levels of six microRNAs in plasma from blood collected in EDTA tubes, Streck DNA tubes, and Streck RNA tubes with levels found in serum. Blood was obtained from five patients with testicular malignant germ cell tumors (GCTs) and two patients with non-GCT testicular malignancies into Sarstedt S-Monovette Z-Gel (serum), Sarstedt S-Monovette K3E (EDTA plasma), Streck Cell-Free DNA BCT, and Streck Cell-Free RNA BCT. Serum was obtained after 30 min clot time by centrifugation at 3000 x g for 10 min. EDTA plasma was obtained from Sarstedt K3EDTA tubes by centrifugation of blood at 1600 x g for 10 min followed by recentrifugation of the supernatant at 14,400 x g for 10 min. Plasma was obtained from both Streck tubes by centrifugation at 300 x g for 20 min followed by at 5000 x g for 10 min. All plasma and serum were stored at -80֯C until analysis. RNA was extracted using miRNeasy serum/plasma kit with QIAzol.

Summary of Findings

Levels of miR-30b-5p, miR-30c-5p, and miR-191-5p were highest in serum followed by EDTA plasma and Streck DNA plasma and were lowest in plasma from Streck RNA tubes. While the standard deviations in miRNA levels were generally low, they were higher in specimens collected in Streck RNA tubes than in other plasma types or in serum. Levels of the hemolysis markers of miR-23a-3p and miR-451a were also highest in serum specimens followed by EDTA plasma, Streck DNA plasma, and finally Streck RNA plasma. Importantly, based on visual inspection and the absorbance at 414 nm, specimens collected in Streck DNA plasma tubes were not considered hemolyzed while those collected in EDTA plasma were hemolyzed. Plasma from specimens in both EDTA and Streck DNA tubes was considered hemolyzed using the Delta CT value (CT of miR-23a-3p – miR-451a), but the value was higher in plasma from EDTA tubes.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    RNAReal-time qRT-PCR
    ProteinSpectrophotometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    EDTA tube
    Gel Separator serum tube
    Streck DNA plasma tube
    Streck RNA plasma tube
    Spectrophotometry SpecificTechnology platform
    Real-time PCR